A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome

Pediatric Nephrology

Volumn 22, Issue 1, 2007, Pages 71-76

  Fujinaga, Shuichiro ^a   Ohtomo, Yoshiyuki ^b   Umino, Daisuke ^a   Takemoto, Mayako ^c   Shimizu, Toshiaki ^c   Yamashiro, Yuichiro ^c   Kaneko, Kazunari ^d  

^a SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^b JUNTENDO UNIVERSITY NERIMA HOSPITAL   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cyclosporine A; Mycophenolate mofetil; Nephrotic syndrome; Predose mycophenolic acid levels monitoring

Indexed keywords

CYCLOSPORIN A; MIZORIBINE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID;

ADOLESCENT; ADULT; ARTERY DISEASE; ARTICLE; BACTERIAL INFECTION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MEGADOSE; DRUG MONITORING; DRUG TREATMENT FAILURE; DRUG USE; ERYTHROPENIA; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; LEUKOPENIA; LIVER DYSFUNCTION; LONG TERM CARE; MALE; NAUSEA; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE RISK; RELAPSE; RISK REDUCTION; STATISTICAL SIGNIFICANCE; THROMBOCYTOPENIA; TREATMENT DURATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYCOPHENOLIC ACID; NEPHROTIC SYNDROME; PROSPECTIVE STUDIES; RECURRENCE;

EID: 33846434421     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-006-0294-0     Document Type: Article

References (24)

1. Capodicasa G, De Santo NG, Nuzzi F, Giordano C (1986) Cyclosporin A in nephrotic syndrome of children - a 14 month experience. Int Pediatr Nephrol 7:69-72
2. Ponticelli C, Rizzoni G, Edefonti A, Altieri P, Riviolta E, Rinaldi S, Ghio L, Lusvarghi E, Gusmano R, Locatelli F, Pasquali S, Castellani A, Della Csa-Alberighi O (1993) A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int 43:1377-1384
3. Niaudet P, Habib R (1994) Cyclosporine in the treatment of idiopathic nephrosis. J Am Soc Nephrol 5:1049-1056
4. Chan TM, Li FK, Tang CSO, Wong RWS, Fang GX, Ji YL, Lau CS, Wong AKM, Tong MKL, Chan KW, Lai KN (2000) Efficacy of mycofenolate mofetil in patients with diffuse proliferative lupus nephritis. N Eng J Med 343:1156-1162
5. Lau KK, Jones DP, Hastings MC, Gaber LW, Ault BH (2006) Short-term outcomes of severe lupus nephritis in a cohort of predominantly African-American children. Pediatr Nephrol 21:655-662
6. Gellermann J, Querfeld U (2004) Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil. Pediatr Nephrol 19:101-104
7. Mendizalbal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J (2005) Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome. Pediatr Nephrol 20:914-919
8. Ulinski T, Dubourg L, Said MH, Parchoux B, Ranchin B, Cochat P (2005) Switch from cyclosporine A to mycophenolate mofetil in nephrotic children. Pediatr Nephrol 20:482-485
9. Bagga A, Hari P, Moudgil A, Jordan SC (2003) Mycophenolate mofetil and predonisolone therapy in children with steroid-dependent nephrotic syndrome. Am J Kidney Dis 42:1114-1120
10. Barletta GM, Smoyer WE, Bunchman TE, Flynn JT, Kershaw DB (2003) Use of mycophenolate mofetil in steroid-dependent and - resistant nephrotic syndrome. Pediatr Nephrol 18:833-837
11. Novak I, Frank R, Vento S, Vergara M, Gauthier B, Trachtman H (2005) Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome. Pediatr Nephrol 20:1265-1268
12. Borrows R, Chusney G, Loucaidou M, James A, Lee J, Tromp JV, Owen J, Cairns T, Griffith M, Hakim N, McLean A, Palmer A, Papalois V, Taube D (2006) Mycophenolic acid 12-h trough level monitoring in renal transplantation: Association with acute rejection and toxicity. Am J Transplant 6:121-128
13. Ohtomo Y, Fujinaga S, Takada M, Murakami H, Akashi S, Shimizu T, Kaneko K, Yamashiro Y (2005) High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity. Pediatr Nephrol 20:1744-1749
14. International Study of Kidney Disease in Children (1981) Primary nephrotic syndrome in children: Clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. Kidney Int 20:765-771
15. International Study of Kidney Disease in Children (1982) Early identification of frequent relapsers among children with minimal change nephrotic syndrome. J Pediatr 101:514-518
16. Langman LJ, Legatt DF, Halloran PF, Yatscoff RW (1996) Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression in renal transplant recipients. Transplantation 62:666-672
17. Fujinaga S, Kaneko K, Muto T, Ohtomo Y, Murakami H, Yamashiro Y (2006) Independent risk factors for chronic cyclosporine-induced nephropathy in children with nephrotic syndrome. Arch Dis Child 91:666-670
18. Kemper MJ, Altrogge H, Ludwig K, Timmermann K, Muller-Wiefel DE (2000) Unfavorable response to cyclophosphamide in steroid-dependent nephrotic syndrome. Pediatr Nephrol 14:772-775
19. Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr (1996) Cyclophosphamide does not benefit patients with focal segmental glomeruloscrelosis. A report of the International Study of Kidney Disease in Children. Pediatr Nephrol 10:590-593
20. Moudgil A, Bagga A, Jordan SC (2005) Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: Current status and future directions. Pediatr Nephrol 20:1376-1381
21. Shalhoub RJ (1974) Pathogenesis of lipoid nephrosis: A disorder of T cell function. Lancet ii:556-559
22. Tredger MJ, Brown NW (2006) Mycophenolate: Better value through monitoring? Transplantation 81:507-508
23. Pape L, Froede K, Strehlau J, Ehrich JH, Offner G (2003) Alterations of cyclosporin a metabolism induced by mycophenolate mofetil. Pediatr Transplant 7:302-304
24. Filler G (2004) Drug interactions between mycophenolate and cyclosporine. Pediatr Transplant 8:201-204